Announcement

Collapse
No announcement yet.

Lancet Respir Med . Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
    No photos found.
Working...
X